{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:34:17Z","timestamp":1787762057036,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Gentamicin has been shown to cause vasodilation in preclinical studies. Hemodynamically significant patent ductus arteriosus (hsPDA) is a commonly observed congenital heart disorder in preterm neonates. Concomitant gentamicin theoretically shall delay the closure\/result in nonclosure of ductus arteriosus (DA). Similarly, hsPDA can alter the pharmacokinetics of gentamicin and so trough gentamicin concentrations. We carried out the present study to evaluate the association between gentamicin use and closure of hsPDA (treated with acetaminophen) as well as the effect of hsPDA on trough concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study was a prospective, observational study that included 60 neonates diagnosed with hsPDA by echocardiography and 102 neonates without hsPDA. Demographic details, size of DA as per echocardiography at the end of treatment with acetaminophen, gentamicin-dosing regimen, and trough concentrations were collected. Standard definitions were adhered in classifying the gestational age, birth weights, and size of DA. The numerical values are reported in median (range).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Neonates with hsPDA had significantly lower daily doses of gentamicin [4.5 (2.5\u201310), 7 (3.2\u201313) mg;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001] but longer duration of therapy [8 (3\u201314), 5 (3\u20137) days;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001] than those without hsPDA in very preterm neonates. No significant differences were observed in the trough concentrations of gentamicin between the groups. No association was observed between gentamicin use and closure of DA. However, those with successful closure of DA received gentamicin for a longer duration [6 (3\u201310), 4 (3\u201314) days;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05] that was independent of acetaminophen duration and had received higher cumulative doses of gentamicin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In conclusion, we observed a significantly longer duration of gentamicin therapy in neonates with hsPDA compared to those without hsPDA. No significant differences were observed in the rates of closure of DA with concomitant gentamicin administration and gentamicin trough concentrations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jpbs.jpbs_420_22","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T13:55:05Z","timestamp":1686059705000},"page":"95-100","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Gentamicin in Neonates with Hemodynamically Significant Patent Ductus Arteriosus"],"prefix":"10.4103","volume":"15","author":[{"given":"Kannan","family":"Sridharan","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulraoof Al","family":"Madhoob","sequence":"additional","affiliation":[{"name":"Neonatology Intensive Care Unit, Department of Pediatrics, Salmaniya Medical Complex, Manama, Kingdom of Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna Al","family":"Jufairi","sequence":"additional","affiliation":[{"name":"Neonatology Intensive Care Unit, Department of Pediatrics, Salmaniya Medical Complex, Manama, Kingdom of Bahrain"},{"name":"Department of Pediatrics, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Al","family":"Ansari","sequence":"additional","affiliation":[{"name":"Neonatology Intensive Care Unit, Department of Pediatrics, Salmaniya Medical Complex, Manama, Kingdom of Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem Al","family":"Marzooq","sequence":"additional","affiliation":[{"name":"Neonatology Intensive Care Unit, Department of Pediatrics, Salmaniya Medical Complex, Manama, Kingdom of Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakariya","family":"Hubail","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Salmaniya Medical Complex, Manama, Kingdom of Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiq Jaafar","family":"Hasan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Salmaniya Medical Complex, Manama, Kingdom of Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"R1-20240829","first-page":"138","article-title":"Patent ductus arteriosus: An overview","volume":"12","author":"Dice","year":"2007","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/chd.12714","article-title":"Molecular and mechanical factors contributing to ductus arteriosus patency and closure","volume":"14","author":"Crockett","year":"2019","journal-title":"Congenit Heart Dis"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.105.592063","article-title":"Patent ductus arteriosus","volume":"114","author":"Schneider","year":"2006","journal-title":"Circulation"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1542\/peds.2005-1528","article-title":"Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less","volume":"117","author":"Koch","year":"2006","journal-title":"Pediatrics"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1469-7793.1998.793bp.x","article-title":"Streptomycin inhibition of myogenic tone, K+-induced force and block of L-type calcium current in rat cerebral arteries","volume":"508","author":"Miller","year":"1998","journal-title":"J Physiol"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0021-5198(19)43205-8","article-title":"Are the cardiovascular effects of gentamicin similar to those of calcium antagonists?","volume":"47","author":"Gotanda","year":"1988","journal-title":"Jpn J Pharmacol"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(01)00717-8","article-title":"Effects of antibiotics on the contractility and Ca2+transients of rat cardiac myocytes","volume":"412","author":"Belus","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/sj.bjp.0702180","article-title":"The mechanism by which aminoglycoside antibiotics cause vasodilation of canine cerebral arteries","volume":"125","author":"Gergawy","year":"1998","journal-title":"Br J Pharmacol"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/AAC.5.6.640","article-title":"Alteration of contractile function and calcium ion movements in vascular smooth muscle by gentamicin and other aminoglycoside antibiotics","volume":"5","author":"Adams","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5114\/ait.2021.103628","article-title":"Drug utilisation in adult, paediatric and neonatal intensive care units, with an emphasis on systemic antimicrobials","volume":"53","author":"Sridharan","year":"2021","journal-title":"Anaesthesiol Intensive Ther"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0301-2115(99)00018-4","article-title":"Risk factors associated with early-onset sepsis in premature infants","volume":"85","author":"Martius","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"H732","DOI":"10.1152\/ajpheart.00838.2013","article-title":"Aminoglycoside-mediated relaxation of the ductus arteriosus in sepsis-associated PDA","volume":"307","author":"Vucovich","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1177\/106002809302701113","article-title":"Drug disposition in neonates with patent ductus arteriosus","volume":"27","author":"Gal","year":"1993","journal-title":"Ann Pharmacother"},{"key":"R14-20240829","doi-asserted-by":"crossref","DOI":"10.1111\/jcpt.13384","article-title":"Intravenous acetaminophen (at 15 mg\/kg\/dose every 6 hours) in critically ill preterm neonates with patent ductus arteriosus: A prospective study","author":"Sridharan","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"R15-20240829","first-page":"1612","article-title":"Intravenous frusemide does not interact pharmacodynamically with acetaminophen in critically ill preterm neonates with patent ductus arteriosus","volume":"25","author":"Sridharan","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2016.03.045","article-title":"Preterm birth: Case definition &guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Quinn","year":"2016","journal-title":"Vaccine"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fped.2017.00147","article-title":"Echocardiographic evaluation of patent ductus arteriosus in preterm infants","volume":"5","author":"Arlettaz","year":"2017","journal-title":"Front Pediatr"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/apa.15541","article-title":"Aminoglycosides were associated with higher rates of surgical patent ductus arteriosus closure in preterm infants","volume":"110","author":"Marissen","year":"2021","journal-title":"Acta Paediatr"},{"key":"R19-20240829","article-title":"Relationship between gentamicin administration and ductal patency in very low birth weight infants","author":"Cakir","year":"2021","journal-title":"Curr Clin Pharmacol"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000457735","article-title":"Effect of patent ductus arteriosus on gentamicin pharmacokinetics in very low birth weight (less than 1,500 g) babies","volume":"10","author":"Watterberg","year":"1987","journal-title":"Dev Pharmacol Ther"},{"key":"R21-20240829","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00003246-199702000-00013","article-title":"Gentamicin pharmacokinetics in neonates with patent ductus arteriosus","volume":"25","author":"Williams","year":"1997","journal-title":"Crit Care Med"},{"key":"R22-20240829","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1023\/A:1012490704731","article-title":"Gentamicin pharmacokinetics in preterm infants with a patent and a closed ductus arteriosus","volume":"23","author":"Touw","year":"2001","journal-title":"Pharm World Sci"},{"key":"R23-20240829","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/jp.2016.120","article-title":"Should gentamicin trough levels be routinely obtained in term neonates?","volume":"36","author":"Ibrahim","year":"2016","journal-title":"J Perinatol"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_420_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:11:33Z","timestamp":1787760693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_420_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_420_22","relation":{},"ISSN":["0976-4879","0975-7406"],"issn-type":[{"value":"0976-4879","type":"print"},{"value":"0975-7406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-09-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}